Crossmark

The development and initial validation of the Breast Cancer Recurrence instrument (BreastCaRe)—a patient-reported outcome measure for detecting symptoms of recurrence after breast cancer

Crossref DOI link: https://doi.org/10.1007/s11136-021-02841-1

Published Online: 2021-04-16

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Høeg, Beverley Lim https://orcid.org/0000-0002-9946-2429
Saltbæk, Lena

Christensen, Karl Bang

Karlsen, Randi Valbjørn

Johansen, Christoffer

Dalton, Susanne Oksbjerg

Bennett, Antonia

Bidstrup, Pernille Envold
Funding

Funding for this research was provided by:

Kræftens Bekæmpelse

Rigshospitalet

Region Sjælland
License Information

Text and Data Mining valid from 2021-04-16

Version of Record valid from 2021-04-16
More Information

Article History

Accepted: 29 March 2021

First Online: 16 April 2021

Compliance with ethical standards

:

: All authors declare no conflict of interest.

Document is current

Any future updates will be listed below